These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 12867135)

  • 21. [Characteristics of university students using stimulants for cognitive enhancement: a pilot study].
    Franke AG; Schwarze CE; Christmann M; Bonertz C; Hildt E; Lieb K
    Psychiatr Prax; 2012 May; 39(4):174-80. PubMed ID: 22318482
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological Cognitive Enhancement in Healthy Individuals: A Compensation for Cognitive Deficits or a Question of Personality?
    Maier LJ; Wunderli MD; Vonmoos M; Römmelt AT; Baumgartner MR; Seifritz E; Schaub MP; Quednow BB
    PLoS One; 2015; 10(6):e0129805. PubMed ID: 26107846
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of stimulants on the continuous performance test (CPT): implications for CPT use and interpretation.
    Riccio CA; Waldrop JJ; Reynolds CR; Lowe P
    J Neuropsychiatry Clin Neurosci; 2001; 13(3):326-35. PubMed ID: 11514638
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of single-dose methylphenidate on cognitive performance in patients with traumatic brain injury: a double-blind placebo-controlled study.
    Kim YH; Ko MH; Na SY; Park SH; Kim KW
    Clin Rehabil; 2006 Jan; 20(1):24-30. PubMed ID: 16502746
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential effects of MDMA and methylphenidate on social cognition.
    Schmid Y; Hysek CM; Simmler LD; Crockett MJ; Quednow BB; Liechti ME
    J Psychopharmacol; 2014 Sep; 28(9):847-56. PubMed ID: 25052243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Haloperidol attenuates Methylphenidate and Modafinil induced behavioural sensitization and cognitive enhancement.
    Alam N; Choudhary K
    Metab Brain Dis; 2018 Jun; 33(3):893-906. PubMed ID: 29470766
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cognitive and emotional behavioural changes associated with methylphenidate treatment: a review of preclinical studies.
    Britton GB
    Int J Neuropsychopharmacol; 2012 Feb; 15(1):41-53. PubMed ID: 21439107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sensitization and cross-sensitization after chronic treatment with methylphenidate in adolescent Wistar rats.
    Valvassori SS; Frey BN; Martins MR; Réus GZ; Schimidtz F; Inácio CG; Kapczinski F; Quevedo J
    Behav Pharmacol; 2007 May; 18(3):205-12. PubMed ID: 17426484
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative Effects of Methylphenidate, Modafinil, and MDMA on Response Inhibition Neural Networks in Healthy Subjects.
    Schmidt A; Müller F; Dolder PC; Schmid Y; Zanchi D; Liechti ME; Borgwardt S
    Int J Neuropsychopharmacol; 2017 Sep; 20(9):712-720. PubMed ID: 28525569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cognitive effects of methylphenidate in healthy volunteers: a review of single dose studies.
    Linssen AM; Sambeth A; Vuurman EF; Riedel WJ
    Int J Neuropsychopharmacol; 2014 Jun; 17(6):961-77. PubMed ID: 24423151
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Substances used and prevalence rates of pharmacological cognitive enhancement among healthy subjects.
    Franke AG; Bagusat C; Rust S; Engel A; Lieb K
    Eur Arch Psychiatry Clin Neurosci; 2014 Nov; 264 Suppl 1():S83-90. PubMed ID: 25214391
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modafinil and methylphenidate for neuroenhancement in healthy individuals: A systematic review.
    Repantis D; Schlattmann P; Laisney O; Heuser I
    Pharmacol Res; 2010 Sep; 62(3):187-206. PubMed ID: 20416377
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cognitive neuroenhancement: false assumptions in the ethical debate.
    Heinz A; Kipke R; Heimann H; Wiesing U
    J Med Ethics; 2012 Jun; 38(6):372-5. PubMed ID: 22228818
    [TBL] [Abstract][Full Text] [Related]  

  • 34. American culture and neuro-cognitive enhancing drugs.
    Flaskerud JH
    Issues Ment Health Nurs; 2010 Jan; 31(1):62-3. PubMed ID: 19951164
    [No Abstract]   [Full Text] [Related]  

  • 35. Prohibition or coffee shops: regulation of amphetamine and methylphenidate for enhancement use by healthy adults.
    Dubljević V
    Am J Bioeth; 2013; 13(7):23-33. PubMed ID: 23767434
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Changing Drug Culture: Use and Misuse of Cognition-Enhancing Drugs.
    Albertson TE; Chenoweth JA; Colby DK; Sutter ME
    FP Essent; 2016 Feb; 441():25-9. PubMed ID: 26881770
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prescription Stimulants' Effects on Healthy Inhibitory Control, Working Memory, and Episodic Memory: A Meta-analysis.
    Ilieva IP; Hook CJ; Farah MJ
    J Cogn Neurosci; 2015 Jun; 27(6):1069-89. PubMed ID: 25591060
    [TBL] [Abstract][Full Text] [Related]  

  • 38. What exactly are the benefits of stimulants for ADHD?
    Advokat C
    J Atten Disord; 2009 May; 12(6):495-8. PubMed ID: 19380518
    [No Abstract]   [Full Text] [Related]  

  • 39. Behavioral response to methylphenidate challenge: influence of early life parental care.
    Engert V; Joober R; Meaney MJ; Hellhammer DH; Pruessner JC
    Dev Psychobiol; 2009 Jul; 51(5):408-16. PubMed ID: 19492313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The potential for misuse and abuse of medications in ADHD: a review.
    Clemow DB; Walker DJ
    Postgrad Med; 2014 Sep; 126(5):64-81. PubMed ID: 25295651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.